ORAL SCAN: Effects Of The Oral JAK Inhibitor Tofacitinib In Combination With Methotrexate On Patient Reported Outcomes In a 24-Month Phase 3 Trial Of Active Rheumatoid Arthritis
Author(s):
Strand, V.; Heijde, D. van der; Zerbini, C.A.F.; Connell, C.A.; Gruben, D.; Riese, R.; Wallenstein, G.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S996-S997
